Recombinant Human CD146 Protein，His

CD146, also known as MCAM (Melanoma Cell Adhesion Molecule), is a transmembrane glycoprotein expressed on the surface of various cell types, including endothelial cells, smooth muscle cells, and certain immune cells. It plays a crucial role in cell adhesion, migration, and signaling, influencing processes such as angiogenesis, immune response, and tissue repair. The study of CD146 has gained attention due to its association with several pathological conditions, including cancer, where it is implicated in tumor progression and metastasis, as well as cardiovascular diseases. The recombinant protein form of CD146 presents a unique opportunity to better understand its functions and regulatory mechanisms. Researchers have been focusing on producing CD146 in a recombinant form to facilitate in vitro studies, enabling the exploration of its role in cell signaling pathways and interactions within the tumor microenvironment. Furthermore, the availability of CD146 recombinant protein could aid in the development of novel therapeutic strategies targeting CD146 to inhibit tumor growth or promote vascular stability. As the understanding of CD146's biology continues to evolve, its potential as a biomarker and therapeutic target remains a promising area of research in both oncology and regenerative medicine. The generation and characterization of CD146 recombinant protein is therefore essential for elucidating its functional roles and therapeutic potential, ultimately contributing to advances in disease management and treatment.